FDA announces FY 2022 GDUFA science and research priorities

Regulatory News

Regulatory NewsJoanne S. Eglovitch

APIsBiologics/ biosimilars/ vaccinesCombination products/companion diagnosticsNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyResearch, Design and Development